Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo-Controlled Trial of Risperidone Augmentation for SSRI-Resistant Civilian PTSD

NCT00133822 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT00133822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00133822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo-Controlled Trial of Risperidone Augmentation for SSRI-Resistant Civilian PTSD
Lead sponsor
Emory University
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2004
Completion date
September 30, 2006
Enrollment
65
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

post-traumatic stress disorders